Related Experiment Video
Updated: Aug 9, 2026
08:34
Isolation of Atrial Myocytes from Adult Mice
Published on: July 25, 2019
B-type natriuretic peptide concentrations and myocardial dysfunction in critical illness
D J Sturgess1, T H Marwick, C J Joyce
1Department of Intensive Care, Princess Alexandra Hospital, University of Queensland, Brisbane, Queensland, Australia.
Anaesthesia and Intensive Care
|April 19, 2006
Summary
B-type natriuretic peptide (BNP) assays show promise for evaluating myocardial dysfunction in critically ill patients. Further research is needed to refine its role in diagnosis, risk stratification, and guiding therapy in diverse critical care settings.
Area of Science:
- Critical Care Medicine
- Cardiology
- Biomarker Research
Background:
- B-type natriuretic peptide (BNP) is a key biomarker for left ventricular dysfunction.
- Point-of-care testing has increased clinical interest and research into BNP's utility.
- BNP's role in critically ill patients requires comprehensive evaluation.
Purpose of the Study:
- To review and synthesize current evidence on BNP assay use in critically ill humans with myocardial dysfunction.
- To explore BNP's application across various organ systems and disease categories in critical care.
Main Methods:
- Systematic review and assimilation of existing research on BNP assays in critically ill populations.
- Information organized by organ system and disease category for clarity.
Main Results:
- BNP assays have been studied in conditions like acute dyspnea and subarachnoid hemorrhage.
- BNP shows potential in diagnosing, assessing severity, stratifying risk, and prognosing cardiac dysfunction.
- Heterogeneity in critically ill patients may necessitate varied BNP cut-off values.
Conclusions:
- BNP assay offers complementary information to conventional methods for cardiac dysfunction evaluation.
- Further research is essential to validate BNP's role in managing critically ill patients with life-threatening cardiac conditions.
- Multi-marker strategies may enhance prognostication and therapy evaluation in critical care settings.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:22Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
01:29Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:30Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...